par Bellmunt, Joaquim;Négrier, Sylvie;Escudier, Bernard;Awada, Ahmad ;Aapro, Matti;SIOG Taskforce,
Référence Critical reviews in oncology/hematology, 69, 1, page (64-72)
Publication Publié, 2009-01
Référence Critical reviews in oncology/hematology, 69, 1, page (64-72)
Publication Publié, 2009-01
Article révisé par les pairs
Titre: |
|
Auteur: | Bellmunt, Joaquim; Négrier, Sylvie; Escudier, Bernard; Awada, Ahmad; Aapro, Matti; SIOG Taskforce, |
Informations sur la publication: | Critical reviews in oncology/hematology, 69, 1, page (64-72) |
Statut de publication: | Publié, 2009-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Bevacizumab |
Elderly | |
Interferon | |
Metastatic renal cell cancer | |
Sorafenib | |
Sunitinib | |
Temsirolimus | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Antineoplastic Agents -- therapeutic use | |
Carcinoma, Renal Cell -- drug therapy | |
Carcinoma, Renal Cell -- secondary | |
Clinical Trials, Phase III as Topic | |
Humans | |
Kidney Neoplasms -- drug therapy | |
Middle Aged | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1040-8428 |
info:doi/10.1016/j.critrevonc.2008.08.002 | |
info:pii/S1040-8428(08)00179-0 | |
info:scp/56449118248 | |
info:pmid/18774306 |